TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSX: VHI) is pleased to announce a three-year expansion licensing agreement of subsidiary Intouch with Health's ("Intouch") patient flow solutions with University Hospitals Dorset NHS Foundation Trust (the "Trust" or "Dorset"). This contract expands upon the Company's existing relationship with the Trust, and marks the 9th Intouch with Health contract announced this quarter.
University Hospitals Dorset NHS Foundation Trust manages three hospitals in Southeast Dorset. It was formed following the merger of Poole Hospital NHS Foundation Trust and The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust. Dorset serves a population of more than 800,000 people, and collectively employs more than 9,000 members of staff. In addition to general hospital services, the Trust provides a range of specialist services and facilities including: (i) medical and clinical oncology services for the whole of Dorset, (ii) a major trauma unit serving a population of more than 500,000 people, (iii) a state-of-the-art cardiology unit, and (iv) an award-winning orthopaedic service providing hip and knee replacements.
Previously purchased Trust-wide licences spanned Intouch with Health products including Flow Manager, Check-in, Calling, Wait Times & Mobile solutions. This expansion licensing agreement will include configuration of all above software solutions across both Bournemouth & Christchurch hospitals, to effectively provide the host of Company patient flow solutions across all three major Trust hospitals.
"This is the 9th Intouch with Health transaction announced since January 2022, demonstrating the continued market demand for our offerings. Expansion agreements such as this contract with University Hospitals Dorset NHS Foundation Trust affirm the value our customers derive from our products and services," said Dan Matlow, CEO of VitalHub Corp. "With this deal, we expand upon our strong existing footprint across the NHS. We look forward to deepening our relationship with Dorset, as we further execute on our growth strategy, and health IT leadership."
UNIVERSITY HOSPITALS DORSET NHS FOUNDATION TRUST
University Hospitals Dorset NHS Foundation Trust is comprised of three hospitals; the Royal Bournemouth Hospital, Poole Hospital and Christchurch Hospital, which merged on 1 October 2020, creating a new organization - providing immense opportunities and benefits to the way patient care is delivered, leading to better outcomes, improved quality and more efficient service delivery. The Trust serves a population of more than 800,000 people, and employs more than 9,000 members of staff. In addition to general hospital services, the Trust provides a range of specialist services and facilities including: (i) medical and clinical oncology services for the whole of Dorset, (ii) a major trauma unit serving a population of more than 500,000 people, (iii) a state-of-the-art cardiology unit, and (iv) an award-winning orthopaedic service providing hip and knee replacements.
Software for Health and Human Services providers designed to simplify the user experience & optimize outcomes.
VitalHub provides technology to Health and Human Services providers including; Hospitals, Regional Health Authorities, Mental Health, Long Term Care, Home Health, Community and Social Services. VitalHub solutions span the categories of Electronic Health Record (EHR), Case Management, Care Coordination, Patient Flow & Operational Visibility, and DOCit Mobile Apps. The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently, VitalHub serves 275+ clients across Canada, USA, UK, Australia, Qatar, and Latvia. VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The Company is publicly traded on the Toronto Stock Exchange (TSX) under the symbol "VHI".
This press release includes forward-looking statements regarding the Corporation and its business, which may include, but is not limited to, statements with respect to the appointment of a new directors. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies, including risks regarding the technology industry, failure to obtain regulatory or shareholder approvals, market conditions, economic factors, the equity markets generally and risks associated with growth and competition. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Corporation undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
Chief Executive Officer, Director
© 2023 Canjex Publishing Ltd. All rights reserved.